Harbin Pharmaceutical Group Co., Ltd. Class A 600664
SSE · China · Health Technology
CNY 7.40+0.26 (+3.64%)
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise |
|---|---|---|---|---|---|---|
| Q2 2026 | 2025-04-26 | — | — | — | CNY 4.17B | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.